NASDAQ: TMCI
Treace Medical Concepts Inc Stock

$10.08+0.26 (+2.65%)
Updated Feb 13, 2025
TMCI Price
$10.08
Fair Value Price
N/A
Market Cap
$627.95M
52 Week Low
$3.92
52 Week High
$15.97
P/E
-10.18x
P/B
5.99x
P/S
1.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$202.86M
Earnings
-$61.52M
Gross Margin
80.6%
Operating Margin
-27.74%
Profit Margin
-30.3%
Debt to Equity
1.03
Operating Cash Flow
-$32M
Beta
1.41
Next Earnings
Feb 25, 2025
Ex-Dividend
N/A
Next Dividend
N/A

TMCI Overview

Treace Medical Concepts Incorporated manufactures and sells medical devices to foot and ankle surgeons in the U.S. Its Lapiplasty procedure allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides the Lapiplasty Mini-Incision precision system. Treace Medical Concepts was founded in 2013 and is headquartered in Ponte Vedra Beach, FL.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine TMCI's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
TMCI
Ranked
#55 of 129

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$33.21A
$10.42A
$47.62A
View Top Medical Device Stocks

Be the first to know about important TMCI news, forecast changes, insider trades & much more!

TMCI News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TMCI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TMCI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TMCI is poor value based on its book value relative to its share price (5.99x), compared to the US Medical Devices industry average (4.36x)
P/B vs Industry Valuation
TMCI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TMCI due diligence checks available for Premium users.

Valuation

TMCI price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-10.18x
Industry
42.41x
Market
38.39x

TMCI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
5.99x
Industry
4.36x
TMCI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TMCI's financial health

Profit margin

Revenue
$45.1M
Net Income
-$15.4M
Profit Margin
-34.1%
TMCI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TMCI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$212.9M
Liabilities
$108.0M
Debt to equity
1.03
TMCI's short-term assets ($157.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TMCI's short-term assets ($157.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TMCI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.8M
Investing
$5.8M
Financing
$8.0k
TMCI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TMCI vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
TMCIC$627.95M+2.65%-10.18x5.99x
KIDSC$606.85M+0.60%-20.37x1.64x
CTKBB$672.39M+0.38%0.01x1.74x
SIBNB$687.79M+1.11%-17.83x4.17x
VREXB$560.73M+1.26%-11.53x1.04x

Treace Medical Concepts Stock FAQ

What is Treace Medical Concepts's quote symbol?

(NASDAQ: TMCI) Treace Medical Concepts trades on the NASDAQ under the ticker symbol TMCI. Treace Medical Concepts stock quotes can also be displayed as NASDAQ: TMCI.

If you're new to stock investing, here's how to buy Treace Medical Concepts stock.

What is the 52 week high and low for Treace Medical Concepts (NASDAQ: TMCI)?

(NASDAQ: TMCI) Treace Medical Concepts's 52-week high was $15.97, and its 52-week low was $3.92. It is currently -36.88% from its 52-week high and 157.14% from its 52-week low.

How much is Treace Medical Concepts stock worth today?

(NASDAQ: TMCI) Treace Medical Concepts currently has 62,297,078 outstanding shares. With Treace Medical Concepts stock trading at $10.08 per share, the total value of Treace Medical Concepts stock (market capitalization) is $627.95M.

Treace Medical Concepts stock was originally listed at a price of $25.53 in Apr 23, 2021. If you had invested in Treace Medical Concepts stock at $25.53, your return over the last 3 years would have been -60.52%, for an annualized return of -26.64% (not including any dividends or dividend reinvestments).

How much is Treace Medical Concepts's stock price per share?

(NASDAQ: TMCI) Treace Medical Concepts stock price per share is $10.08 today (as of Feb 13, 2025).

What is Treace Medical Concepts's Market Cap?

(NASDAQ: TMCI) Treace Medical Concepts's market cap is $627.95M, as of Feb 14, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Treace Medical Concepts's market cap is calculated by multiplying TMCI's current stock price of $10.08 by TMCI's total outstanding shares of 62,297,078.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.